Please assess the completion status of the following clinical trial:

Trial Title: Effect of Repeated Administration of Liraglutide on Insulinogenic Indices

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Weight 50-100 kg~Exclusion Criteria:~* Chronic disease~* Concomitant drug use~* Pregnancy or lactation~* Fasting glucose \>6 mmol/L.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Liraglutide (Type: EXPERIMENTAL): Liraglutide 0.6 mg/day subcutaneously.

Based on this trial design, predict the completion outcome and termination type (if applicable).